What is Quartesian?
Quartesian operates as the "Clinical Data Company," dedicated to furnishing organizations engaged in clinical studies with critical data insights. The company distinguishes itself through a potent combination of deep technical acumen and extensive industry experience, enabling the delivery of clinical data services that are not only rapid and efficient but also cost-effective. This approach caters to a diverse clientele, supporting businesses of all sizes and across various study phases. With a global footprint, Quartesian serves over 250 customers worldwide, consistently delivering quality and innovation in its specialized data services.
How much funding has Quartesian raised?
Quartesian has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Quartesian?
The substantial capital infusion, particularly the recent strategic investment, signals Quartesian's readiness for accelerated growth and market expansion. As a company operating in the late-stage funding environment, this financing is likely earmarked for scaling operations, enhancing its technological infrastructure, and potentially broadening its service portfolio to address emerging needs in clinical data analytics and management. The strategic nature of the investment suggests a focus on strengthening market position and driving further innovation in clinical trial data intelligence.
See full Quartesian company page
